April 7, 2025 03:58 PM EDT

Minnesota federal judge dismisses challenge from AbbVie, AstraZeneca to state's 340B law

Max Bayer

Pharma Reporter

A federal judge in Minnesota knocked down challenges from two drugmakers against a state law that the companies argued overly expanded the scope of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Minnesota federal judge dismisses challenge from AbbVie, AstraZeneca to state's 340B law

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

New fund will pressure flailing biotechs, as investor frustration boils over

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

Merck KGaA closes in on SpringWorks deal at $3.5B price point

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Min­neso­ta fed­er­al judge dis­miss­es chal­lenge from Ab­b­Vie, As­traZeneca to state's 340B law

Pharma Reporter

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

Minnesota federal judge dismisses challenge from AbbVie, AstraZeneca to state's 340B law